EIM
KPRX icon

Essex Investment Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Essex Investment Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-14
Closed -$39K – 423
2018
Q2 		$39K Buy
+14
New +$39.5K ﹤0.01% 395

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Essex Investment Management's KPRX Position: Q3 2018 in Review

Essex Investment Management sold out of Kiora Pharmaceuticals (KPRX) in Q3 2018, closing a stake of 14 shares — an estimated $39K sold.

Essex Investment Management first reported a position in KPRX in Q2 2018 and held it in 1 quarter. The position peaked at $39K in Q2 2018. 20 funds tracked by Wall St. Rank hold KPRX as of Q3 2018.

  • Essex Investment Management reported no remaining Kiora Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Essex Investment Management sold 14 Kiora Pharmaceuticals shares in Q3 2018, an estimated $39K.
  • Essex Investment Management first reported a position in Kiora Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Essex Investment Management's Kiora Pharmaceuticals position peaked at $39K in Q2 2018.
  • 20 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2018.

Based on Essex Investment Management's 13F filing for Q3 2018, filed 16 Oct 2018.